methylprednisolone has been researched along with prednimustine in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
Bodenstein, H; Dietzfelbinger, H; Eimermacher, H; Engert, A; Freund, M; Herrmann, R; Hiddemann, W; Kreuser, ED; Landys, K; Nahler, M; Neubauer, A; Parwaresch, R; Reuss-Borst, M; Stauder, R; Stein, H; Tiemann, M; Tirier, C; Trümper, L; Unterhalt, M | 1 |
1 trial(s) available for methylprednisolone and prednimustine
Article | Year |
---|---|
Prednimustine, mitoxantrone (PmM) vs cyclophosphamide, vincristine, prednisone (COP) for the treatment of advanced low-grade non-Hodgkin's lymphoma. German Low-Grade Lymphoma Study Group.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Cyclophosphamide; Disease-Free Survival; Female; Humans; Hydrocortisone; Lymphoma, Non-Hodgkin; Male; Methotrexate; Methylprednisolone; Middle Aged; Mitoxantrone; Prednimustine; Remission Induction; Treatment Outcome; Vincristine | 1996 |
1 other study(ies) available for methylprednisolone and prednimustine
Article | Year |
---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |